Skip to content
MedsAcross

Medicine

Azacitidine 100 mg powder for injection

Azacitidine · Intravenous, subcutaneous
Available on requestPrescription onlyUS FDAGeneric name

Azacitidine 100 mg powder for injection is a generic prescription medicine for intravenous, subcutaneous use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store unreconstituted vials at 25º C (77º F), excursions permitted to 15º -…

Key facts

Active ingredient (INN)
Azacitidine
Brand
Sold under the generic name
Strength
100 mg
Dosage form
Powder for injection
Route
Intravenous, subcutaneous
Packs
1 injection, 1 vial and 18 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaAccord HealthcareIndiaCamber PharmaceuticalsIndiaMSN LaboratoriesIndiaReliance Life SciencesIndiaBluePoint LaboratoriesMeitheal PharmaceuticalsAmneal PharmaceuticalsApotexArmas Pharmaceuticals
Origin register
US FDA, United States
Storage
Store unreconstituted vials at 25º C (77º F), excursions permitted to 15º - 30º C (59º - 86º F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L01BC07 Azacitidine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 September 2013
Identifiers
RxCUI 485246DailyMed set ID 2d15b3ec-ed08-48c6-a400-34e55974afad, 81366ec1-9689-4857-ded6-3d6342fe5132, 5804d999-96eb-4fd1-b7d8-de7867c5f1d6 +18NDC 72572-020, 16714-927, 58458-002 +18Application ANDA212580, ANDA201537, ANDA217453 +8

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 injection, powder, lyophilized, for solution in 1 carton43598-305-62Dr. Reddy's LaboratoriesIndia19 September 2013
1 injection, powder, lyophilized, for solution in 1 carton43598-465-62Dr. Reddy's LaboratoriesIndia19 June 2015
1 injection, powder, lyophilized, for solution in 1 carton43598-678-11Dr. Reddy's LaboratoriesIndia13 December 2017
1 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial75907-225-11Dr. Reddy's LaboratoriesIndia1 March 2025
1 injection, powder, lyophilized, for solution in 1 carton16729-306-10Accord HealthcareIndia9 January 2019
1 injection, powder, lyophilized, for solution in 1 carton31722-365-31Camber PharmaceuticalsIndia15 October 2024
1 injection, powder, lyophilized, for solution in 1 carton69539-112-01MSN LaboratoriesIndia18 May 2024
1 vial, glass in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, glass58458-002-02Reliance Life SciencesIndia30 July 2025
1 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose71288-115-30Meitheal Pharmaceuticals2 November 2020
1 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose71288-153-95Meitheal Pharmaceuticals2 November 2020
1 injection, powder, lyophilized, for solution in 1 carton70121-1237-1Amneal Pharmaceuticals9 February 2022
1 injection, powder, lyophilized, for solution in 1 carton60505-6271-1Apotex23 January 2024
1 injection, powder, lyophilized, for solution in 1 carton72485-201-01Armas Pharmaceuticals10 September 2018
1 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial0143-9606-01Hikma Pharmaceuticals8 June 2020
1 injection, powder, lyophilized, for solution in 1 carton83774-102-01Pilnova Pharma14 March 2024
1 injection, powder, lyophilized, for solution in 1 carton0781-3491-94Sandoz1 November 2024
1 vial, glass in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, glass70069-857-01Somerset Therapeutics29 August 2025
1 injection, powder, lyophilized, for solution in 1 carton68001-313-56BluePoint Laboratories1 July 2017
1 injection, powder, lyophilized, for solution in 1 carton68001-620-54BluePoint Laboratories10 January 2025
1 injection, powder, lyophilized, for solution in 1 carton72572-020-01Civica12 September 2025
1 injection, powder, lyophilized, for solution in 1 carton16714-927-01NorthStar RxLLC8 May 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 May 2004Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Azacitidine 100 mg powder for injection.

Compare 1

Other strengths and forms of Azacitidine

Clinical summary

Azacitidine is a nucleoside metabolic inhibitor indicated for the treatment of adult patients with FAB myelodysplastic syndrome (MDS) subtypes, among other approved uses. MedsAcross supplies Azacitidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Azacitidine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Azacitidine 100 mg powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.